Multiple Sclerosis Clinical Trials in Philadelphia

Showing 521-540 of 634 trials

A Novel Prosocial Online Support Group for Distressed Breast Cancer Survivors

NCT01396174

The investigators hypothesize that breast cancer survivors participating in a prosocial online support group will have a significantly lower mean level of psychological symptoms (anxiety/depression) and higher mean level of sense of purpose post-intervention than participants in a standard online support group.

Breast Neoplasms

Temple University184 participantsStarted Aug 2011

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

NCT00831844

This phase II trial is studying the side effects and how well cixutumumab works in treating patients with relapsed or refractory solid tumors. Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them.

Adult RhabdomyosarcomaAdult Synovial SarcomaChildhood Hepatoblastoma+13 more

National Cancer Institute (NCI)116 participantsStarted Jan 2009

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Downey, California, United States +102 more locations

A Novel Prosocial Online Support Group for Distressed Breast Cancer Survivors

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Multiple Sclerosis Trials in Other Cities

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

Natalizumab High Titer Immunogenicity and Safety

A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

iCAT for Recurrent/Refractory/HR Solid Tumors

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

NP2 Enkephalin For Treatment of Intractable Cancer Pain

MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer

Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis

Other Conditions in Philadelphia